상세 보기
A pilot study of the pharmacokinetics of the modified-release once-daily tacrolimus formulation administered to living-donor liver transplant recipients
- Song G.-W.;
- Lee S.-G.;
- Hwang S.;
- Kim K.-H.;
- Kim W.-J.;
- 외 3명
WEB OF SCIENCE
5SCOPUS
5초록
Objectives: Sustained-release once-daily tacrolimus pharmacokinetics have not yet been characterized in de novo living-donor liver transplant recipients. Here, a 12-week, phase IV, single center, open-label, pros -pective pilot study was conducted to investigate the pharmacokinetics of this formulation in these patients. Materials and Methods: Patients received continuous intravenous infusion of tacrolimus on days 0 to 5 after transplant, which was followed by oral once-daily sustained-release tacrolimus. Two 24-hour pharma -cokinetics profiles were generated for 10 patients on days 6 and 14. Secondary endpoints were minimum (trough level) and maximum whole blood concent -rations, time to maximum concentration, and incidences of acute rejection, patient and graft survival, and adverse events. Results: Mean doses (± standard deviation) of sustained-release tacrolimus on days 6 and 14 were 0.14 ± 0.03 and 0.17 ± 0.04 mg/kg. Levels were within the recommended range throughout the study. When the actual dose was examined, area under the curve from 0 to 24 hours on day 14 was 1.8-fold higher than that on day 6 (423.9 vs 235.7 ng × h/mL). When tacrolimus was normalized to 0.1 mg/kg, area under the curve from 0 to 24 hours on day 14 was 1.5-fold higher than on day 6 (279.3 vs 183.4 ng × h/mL). When we used the actual dose, we found the correlation coefficient between area under the curve from 0 to 24 hours and trough level to be higher on day 6 (r = 0.87) than on day 14 (r = 0.691). No acute rejections, graft losses, patient deaths, or drug-related adverse events were reported. Conclusions: Initial intravenous followed by sustained-release tacrolimus was safe and efficacious in living-donor liver transplant recipients. The mean area under the curve from 0 to 24 hours on day 14 was higher than previously reported; this difference may reflect cautious dosing regimens. © Başkent University 2016 Printed in Turkey. All Rights Reserved.
키워드
- 제목
- A pilot study of the pharmacokinetics of the modified-release once-daily tacrolimus formulation administered to living-donor liver transplant recipients
- 저자
- Song G.-W.; Lee S.-G.; Hwang S.; Kim K.-H.; Kim W.-J.; Sin M.-H.; Yoon Y.-I.; Tak E.-Y.
- 발행일
- 2016-08
- 유형
- Article
- 권
- 14
- 호
- 4
- 페이지
- 412 ~ 418
- 언어
- ENG
- 출판사
- Baskent University
- 발행국가
- 튀르키예
- 분량
- 7 페이지
- ISSN
- E 2146-8427
P 1304-0855